Call Now Open

2025 Oxford-Harrington Rare Disease Scholar Award

You've just added:

Home / News

Press Releases

April 13, 2016

Charles River Laboratories and BioMotiv Enter Into Strategic Partnership

WILMINGTON, MA, April 13, 2016 – Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development. Through this partnership, Charles River will... Continue Reading

March 15, 2016

Harrington Discovery Institute and The American Society for Clinical Investigation honor Jeffrey M. Friedman, MD, PhD

2016 Harrington Prize for Innovation in Medicines Recognizes Discovery of Leptin and the Leptin-Mediated Pathway Continue Reading

February 29, 2016

Harrington Scholar-Innovator Darren Carpizo Launches Z53 Therapeutics, a New Oncology Start-Up Combating Cancer-Associated Mutation

Formed by BioMotiv and Rutgers UniversityCLEVELAND AND NEW BRUNSWICK— FEBRUARY 29, 2016— BioMotiv, a drug development accelerator associated with The Harrington Project, and Rutgers, the State University of New Jersey, are announcing the formation of a new biotechnology startup, Z53 Therapeutics. Z53 Therapeutics aims to... Continue Reading

January 13, 2016

Announcing our 2016 Harrington Scholar-Innovator Award Recipients

Cleveland, Ohio – The Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio has announced the 2016 recipients of Harrington Scholar-Innovator Awards. The awards support breakthrough work of physician-scientists whose discovery research shows promise of advancing the standard of care.The Harrington... Continue Reading

January 08, 2016

Harrington Distinguished Scholar Announces Company Collaboration with Bristol-Myers Squibb

Cleveland– January 8, 2016 – Dual Therapeutics, LLC (“Dual Therapeutics”) today announced a strategic collaboration with Bristol-Myers Squibb (NYSE: BMY) to advance small molecule compounds for the treatment of cancer and other diseases. Dual Therapeutics’ small-molecule modulators simultaneously block multiple cancer... Continue Reading

February 10, 2015

Harrington Discovery Institute and the American Society for Clinical Investigation honor National Cancer Institute's researcher Douglas R. Lowy, MD

2015 Harrington Prize for Innovation in Medicine Recognizes Discoveries Leading to the Human Papillomavirus (HPV) Vaccine Continue Reading

February 12, 2014

Harrington Discovery Institute and the American Society for Clinical Investigation honor Johns Hopkins Pediatric Cardiologist and Geneticist Harry C. Dietz, MD

2014 Harrington Prize for Innovation in Medicine Recognizes Fundamental Insights into the Biology of Marfan Syndrome and Related Disorders Continue Reading

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.